WHOCC
Postal address:
Norwegian Institute of Public Health
WHO Collaborating Centre for Drug Statistics Methodology
Postboks 222 Skøyen
0213 Oslo
Norway

Visiting/delivery address:
Myrens verksted 6H
0473 Oslo
Norway

Tel:  +47 21 07 81 60
E-mail:
 
Copyright/Disclaimer

New ATC 5th levels

List of latest ATC/DDD decisions from the WHO International Working Group for Drug Statistics Methodology. Comments or objections to the decisions should be forwarded to the WHO Collaborating Centre for Drug Statistics Methodology within the deadline (see list). If no objections are received, the new ATC/DDD decisions will be considered final and included in the ATC/DDD Index. In the list final indicates that the date for objection has expired. The year of implementation in the ATC/DDD Index is given in the list.

Please note that the ATC and DDD alterations are only valid and implemented in the coming annual updates of January 1st.

ATC codeATC level nameDeadline for objection to temporary codesImplementation in ATC/DDD index
A04AD15fosaprepitantFinal2027
A04AD16difenidolFinal2027
A08AA13benzfetamineFinal2027
A08AA14phendimetrazineFinal2027
A10AE08insulin efsitora alfa20.08.20262027
A10BJ08efsubaglutide alfa20.08.20262027
A16AA08valineFinal2027
A16AX31elamipretide20.08.20262027
B01AC29becondogrel20.08.20262027
B02BD19dalnacogene ponparvovecFinal2027
B02BX13denecimig20.08.20262027
B02BX14rilzabrutinib20.08.20262027
B05DA01icodextrinFinal2027
B06AA11berahyaluronidase alfa20.08.20262027
B06AC10deucrictibant20.08.20262027
B06AX08anselamimabFinal2027
B06AX09etuvetidigene autotemcel20.08.20262027
C01EB26aficamten20.08.20262027
C03EA15benzthiazide and potassium-sparing agentsFinal2027
C09BX08ramipril and nebivolol20.08.20262027
C09DX10telmisartan, amlodipine and indapamide20.08.20262027
C10AX20plozasiran20.08.20262027
C10AX21olezarsen20.08.20262027
C10AX22obicetrapib20.08.20262027
C10BA17obicetrapib and ezetimibe20.08.20262027
D03AX19prademagene zamikeracelFinal2027
D04AX02crotamitonFinal2027
D06BB14vidarabine20.08.20262027
D11AH13rocatinlimab20.08.20262027
G04BD30solifenacin and mirabegron20.08.20262027
H01AX02crinecerfont20.08.20262027
J04AM13rifapentine and isoniazid20.08.20262027
J05AF14pradefovir20.08.20262027
J05AR30doravirine and islatravir20.08.20262027
J05AX34bepirovirsen20.08.20262027
J06AA07ricin antitoxin20.08.20262027
J06BE03atoltivimab, maftivimab and odesivimabFinal2027
J07AH12meningococcus A, C, Y, W-135, X, pentavalent purified polysaccharides antigen conjugated20.08.20262027
L01EA07vamotinib20.08.20262027
L01EB13andamertinib20.08.20262027
L01EB14sunvozertinib20.08.20262027
L01EB15zorifertinib20.08.20262027
L01ED06ensartinib20.08.20262027
L01EN05lirafugratinib20.08.20262027
L01EP04vebreltinib20.08.20262027
L01EX31pimicotinib20.08.20262027
L01EX32taletrectinib20.08.20262027
L01EX33catequentinib20.08.20262027
L01FD08trastuzumab rezetecan20.08.20262027
L01FF17cosibelimab20.08.20262027
L01FF18penpulimab20.08.20262027
L01FF19sintilimab20.08.20262027
L01FF20pucotenlimabFinal2027
L01FX40zenocutuzumab20.08.20262027
L01FX41telisotuzumab vedotin20.08.20262027
L01XA06nedaplatinFinal2027
L01XK08fuzuloparib20.08.20262027
L01XL13afamitresgene autoleucelFinal2027
L01XL14inaticabtagene autoleucel20.08.20262027
L01XL15varnimcabtagene autoleucelFinal2027
L01XL16talicabtagene autoleucelFinal2027
L01XL17sepidleucelFinal2027
L01XL18bamileucel20.08.20262027
L01XU01glecirasib20.08.20262027
L01XX88sonrotoclax20.08.20262027
L01XX89ziftomenib20.08.20262027
L02BA06imlunestrant20.08.20262027
L02BB07rezvilutamide20.08.20262027
L02BX05relacorilant20.08.20262027
L03AX26zopapogene imadenovec20.08.20262027
L03AX27murcidencel20.08.20262027
L04AC28icotrokinra20.08.20262027
L04AC29xeligekimab20.08.20262027
L04AG20veligrotug20.08.20262027
L04AG21ianalumab20.08.20262027
L04AJ12gefurulimab20.08.20262027
L04AJ13narsoplimab20.08.20262027
L04AX12 remestemcelFinal2027
L04AX13amimestrocelFinal2027
M03BX10metaxaloneFinal2027
M05BD02navepegritide20.08.20262027
M09AX18atleradstrocelFinal2027
M09AX21tenvumestrocelFinal2027
N02AC56dipipanone and cyclizine20.08.20262027
N02AF03levorphanolFinal2027
N02AF03levorphanol20.08.20262027
N02BG13suzetrigine20.08.20262027
N02BG14opiranserin20.08.20262027
N02CC54rizatriptan and meloxicam20.08.20262027
N05CJ04vornorexant20.08.20262027
N07XX28lenzumestrocelFinal2027
N07XX29elapomestrocelFinal2027
P01CX05acoziborole20.08.20262027
R01AA16levmetamfetamineFinal2027
R02AA22 amylmetacresolFinal2027
R02AX04diclofenac acid20.08.20262027
R03AC20arformoterolFinal2027
R03AC21levosalbutamolFinal2027
R03CC16levosalbutamolFinal2027
R03DC05 zileutonFinal2027
R03DX13brensocatib20.08.20262027
R06AX33bepotastineFinal2027
S01ED07levobetaxololFinal2027
S01EX08phentolamine20.08.20262027
S01GX14pemirolastFinal2027
S01GX15 bepotastineFinal2027
S01XA34tacrolimus20.08.20262027
S01XA35 revakinagene taroretcelFinal2027
S01XA36acoltremon20.08.20262027
S01XA37recoflavone20.08.20262027
S01XA38neltependocelFinal2027
S02AA19lomefloxacin20.08.20262027
S02AA21finafloxacinFinal2027
S03AA09lomefloxacin20.08.20262027
V03AB39levallorphanFinal2027
V03AB40pentetic acid20.08.20262027
V04CX14gaxiloseFinal2027
V09IX21PSMA-JK-7 (18F)20.08.20262027

Last updated: 2026-07-17